| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/11/2002 | WO2000076480A9 Pharmaceutical materials and methods for their preparation and use |
| 07/11/2002 | WO2000075173A3 Peptide fragments of colostrinin |
| 07/11/2002 | WO2000073263A9 Cytofectin dimers and methods of use thereof |
| 07/11/2002 | WO2000066179A9 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 07/11/2002 | US20020091375 Stent lining |
| 07/11/2002 | US20020091270 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 07/11/2002 | US20020091230 Made from a bis/gamma-hydroxyhydrocarbyl/ ester of terephthalic acid and a phosphorodichloridate; biocompatible before and upon biodegradation |
| 07/11/2002 | US20020091229 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 07/11/2002 | US20020091159 Stable solid dosage forms of amino acids and processes for producing same |
| 07/11/2002 | US20020091120 2-substituted heterocyclic compounds for treating multidrug resistance |
| 07/11/2002 | US20020091108 Stable salts of O-acetylsalicylic acid with basic amino acids |
| 07/11/2002 | US20020091101 Immunoisolation of a cell; use of biomedically pure, p-GlcNAc of high molecular weight and consistent properties. |
| 07/11/2002 | US20020091100 Also cromolyn salts or esters; may be in combination with a corticosteroid; may also contain an antiphlogistic compound and hyaluronic acid |
| 07/11/2002 | US20020091099 Orally active a1 adenosine receptor agonists |
| 07/11/2002 | US20020091098 Also administering to the subject an effective amount of an mda-7 protein. |
| 07/11/2002 | US20020091074 Medical compositions, dressings and methods for treating microbial infections of skin lesions |
| 07/11/2002 | US20020090445 Flavoring systems for pharmaceutical compositions and methods of making such compositions |
| 07/11/2002 | US20020090406 Tahitian noni juice on COX-1 and COX-2 and tahitian noni juice as a selective COX-2 inhibitor |
| 07/11/2002 | US20020090399 Cytoprotective biocompatible containment systems for biologically active materials and methods of making same |
| 07/11/2002 | US20020090398 Flowable, biocompatible, branched thermoplastic polymer used to form solid matrices such as implants and controlled-release, drug-formulations in a body |
| 07/11/2002 | US20020090397 Novel suppository form comprising an acid-labile active compound |
| 07/11/2002 | US20020090396 Administering a sustained release pharmaceutical dosage form including ranolazine for therapy of cardiovascular disease selected from arrhythmias, variant and exercise-induced angina, and myocardial infarction |
| 07/11/2002 | US20020090395 Anti-inflammatory pharmaceutical formulations |
| 07/11/2002 | US20020090394 Paroxetine controlled release compositions |
| 07/11/2002 | US20020090393 Retains ligustilide as a principal active constituent in angelica essential oil with a maximal limitation |
| 07/11/2002 | US20020090392 For therapy of tumors |
| 07/11/2002 | US20020090390 Device and method for treating urinary incontinence in females |
| 07/11/2002 | US20020090389 Implantable, intravascular device for treating a medical disorder associated with presence of a particular molecule in systemic circulation of a mammal, when implanted, device removes or reduces concentration of molecule in blood stream |
| 07/11/2002 | US20020090388 Implantable, for sustained delivery of a drug directly into systemic circulation of an animal |
| 07/11/2002 | US20020090387 Insecticidal combination to control mammal fleas in particular fleas in particular fleas on cats and dogs |
| 07/11/2002 | US20020090383 Phosphatidyl oligoglycerols |
| 07/11/2002 | US20020090377 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/11/2002 | US20020090375 Stratified and cryogenically stored vaccines, process for their preparation |
| 07/11/2002 | US20020090367 Therapeutic treatment of upper respiratory infections |
| 07/11/2002 | US20020090365 For therapy of vaginal and gastrointestinal infections |
| 07/11/2002 | US20020090351 Hair care cosmetics |
| 07/11/2002 | US20020090345 Dry powder inhalation formulations which are capable of providing a slow, continuous release of drug while also being biodegradable or expellable from the pulmonary or nasal tract; bioavailability |
| 07/11/2002 | US20020090344 Administering a dose of a mixture of lipid crystals, as an aerosol; propellants are evaporated as aerosolized mixture of lipid crystals come into contact with, and deposits upon the epithelial lining of the upper respiratory system |
| 07/11/2002 | US20020090343 For use in production of effervescent product such as adsorbent, a dry lubricant, dry solvent, fertilizer, fragrance dispenser, fungicide, insecticide, herbicide, packing material, rust inhibitor, and sanitizer |
| 07/11/2002 | US20020089080 Method for manufacturing a chitosan microflake |
| 07/11/2002 | US20020088781 Pore structures for reduced pressure aerosolization |
| 07/11/2002 | DE10065561A1 Tetraetherlipidderivate und Tetraetherlipidderivate enthaltende Liposomen und Lipidagglomerate sowie deren Verwendung Tetraether lipid and tetraether lipid-containing liposomes and lipid agglomerates and their use |
| 07/11/2002 | DE10064950A1 Thixotropes Nasenspray Thixotropic nasal spray |
| 07/11/2002 | DE10064870A1 Schwefelhaltige Amphiphile für den Transfer von biologisch aktiven Molekülen in Zellen Sulfur-containing amphiphiles for the transfer of biologically active molecules into cells |
| 07/11/2002 | DE10064732A1 Enterale Zubereitung zur Stärkung des Immunsystems Enteral preparation for strengthening the immune system |
| 07/11/2002 | DE10064219A1 Neue pharmazeutische Zusammensetzung von wasserlöslichen oder schwer wasserlöslichen Wirkstoffen New pharmaceutical composition of water-soluble or poorly water-soluble drugs |
| 07/11/2002 | DE10061944A1 Microparticles for delayed release of drugs, especially proteins or peptides, from polymer matrix, prepared by encapsulation under controlled conditions to maximize drug loading and minimize initial burst phase release |
| 07/11/2002 | CA2680475A1 Sustained-release preparation |
| 07/11/2002 | CA2433781A1 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
| 07/11/2002 | CA2433580A1 Tertiary perfluorocycloamines as a basis for gas transport emulsions and process for preparing thereof |
| 07/11/2002 | CA2433361A1 Controlled release systems for polymers |
| 07/11/2002 | CA2433263A1 Stabilized pharmaceutical composition in lyophilized form |
| 07/11/2002 | CA2432362A1 Micellar colloidal pharmaceutical compositions containing a lipophilic active principle |
| 07/11/2002 | CA2432184A1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 07/11/2002 | CA2432136A1 Pharmaceutical emulsion preparation |
| 07/11/2002 | CA2431413A1 Stable skin conditioning compositions containing retinoid boosters |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1221326A2 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/10/2002 | EP1221325A2 A wound healing antiscarring topical composition of centella and ginseng |
| 07/10/2002 | EP1221316A1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 07/10/2002 | EP1221315A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 07/10/2002 | EP1221314A1 New crystalline form of omeprazole |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220887A1 Protein-containing granules and granule formulations |
| 07/10/2002 | EP1220869A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 07/10/2002 | EP1220849A2 Bicyclic compounds composition and method for stabilizing the same |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220702A1 Closed exchange system |
| 07/10/2002 | EP1220699A1 Medicament pack |
| 07/10/2002 | EP1220693A1 Formulations for delivery of osteogenic proteins |
| 07/10/2002 | EP1220690A2 Injection vehicle for polymer-based formulations |
| 07/10/2002 | EP1220685A2 Pharmaceutical compositions of fibrinolytic agent |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220681A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 07/10/2002 | EP1220670A1 Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
| 07/10/2002 | EP1220667A2 Treating endometriosis or infertility, or improving fertility |
| 07/10/2002 | EP1220666A2 Methods for modulating the human sexual response |
| 07/10/2002 | EP1220663A1 Superficial therapeutic system for topically applying acetylsalicylic acid, for the treatment of acne-related diseases |
| 07/10/2002 | EP1220662A1 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 07/10/2002 | EP1220661A2 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid |
| 07/10/2002 | EP1220660A1 Tablets with a gellan gum coating |
| 07/10/2002 | EP1220659A1 Pharmaceutical products and methods of fabrication therefor |
| 07/10/2002 | EP1220658A1 Melt granulated composition and modified release dosage form prepared from said composition |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/10/2002 | EP1220656A2 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 07/10/2002 | EP1073451B1 Deltorphine for treating ischemia |
| 07/10/2002 | EP1071410B1 Ionic aqueous composition containing levomenthol |
| 07/10/2002 | EP1063942A4 Liquid polymeric compositions for controlled release of bioactive substances |
| 07/10/2002 | EP1028714A4 Vitamin composition |
| 07/10/2002 | EP0967967B1 Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin |
| 07/10/2002 | EP0949929B1 Use of plant extract for inhibition of haemophilus influenzae |
| 07/10/2002 | EP0820322B1 Metered dose inhaler for fluticasone propionate |
| 07/10/2002 | EP0679088B1 Pulmonary delivery of active fragments of parathyroid hormone |
| 07/10/2002 | CN2499032Y Convenient medicine plaster |
| 07/10/2002 | CN2499031Y Slow-releasing capsule with two medicine storage cavity |
| 07/10/2002 | CN1358233A Oligosaccharide-supplying compositions |
| 07/10/2002 | CN1358225A Cleaning compositions and tablets |
| 07/10/2002 | CN1358190A Propargyl phenyl ether A2A receptor agonists |
| 07/10/2002 | CN1358104A Low dose estrogen interupted hormone replacement therapy |
| 07/10/2002 | CN1358090A Levodopa/carbidopa/entacapone pharmaceutical preparation |